Thursday April 15, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

February 2007

Pre- and Post-Conference Workshops

by BPI Contributor
Add Comment
February 1, 2007

Biopharmaceutical Production Outsourcing Matures

by BPI Contributor
Add Comment
February 1, 2007

Plenary Addresses

by BPI Contributor
Add Comment
February 1, 2007

Biotech’s Comeback in France

by BPI Contributor
Add Comment
February 1, 2007

Looking Back at BPI San Francisco

by BPI Contributor
Add Comment
February 1, 2007

Agenda at a Glance

by BPI Contributor
Add Comment
February 1, 2007

High-Throughput Glycoanalysis for Biopharmaceutical Development and Manufacturing

by BPI Contributor
Add Comment
February 1, 2007

A New, Modern Chromatography Sorbent Production Facility

by BPI Contributor
Add Comment
February 1, 2007

Formulation and Drug Delivery

by BPI Contributor
Add Comment
February 1, 2007

Analytical Methods for Biologics

by BPI Contributor
Add Comment
February 1, 2007
  • 1
  • 2
  • 3
  • >

Editor’s Choice

  • BioProcess Insider

    Horseshoe crabs: COVID-19 further threat to ‘blue blood’ of industry

  • BioProcess Insider

    Catalent: ‘Dedicated Moderna line frees space for our non-COVID customers’

  • Sponsored Content

    CHO Cell Culture Media & Feeds

  • BioProcess Insider

    Sanofi to build $700m Canadian flu vaccine plant

  • BioProcess Insider

    Turning a corner in CAR-T: FDA approves ide-cel

  • Sponsored Content

    Crude Sample Analysis in Process Development: Time and Cost Savings

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 4 weeks ago
  • Tweet Avatar RT @Dan5tanton: Thermo Fisher’s $600 million CAPEX has got the trade press salivating. But similar statements, expansions underway,… https://t.co/5xHNdfJwRw 1 month ago
  • Tweet Avatar RT @Dan5tanton: Calls for standardization to boost manufacturing agility by executives from Novavax, Fujifilm, and Biocon after a C… https://t.co/UJO2CH09K8 1 month ago
  • Tweet Avatar VIVEbiotech has responded to the high demand for lentiviral vectors in the cell and gene therapy space by expanding… https://t.co/y11zPEBs0E 2 months ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Lonza dedicates suite to make Altimmune’s nasal COVID-19 vaccine

  • BioProcess Insider

    Lifecycle approach could cut cell and gene therapy costs

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

  • BioProcess Insider

    BIO: Sputnik V should be judged on same data as other COVID jabs

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events